Clinical microbio Lecture 2

Hemolysis on Blood Agar and Colony Morphology

• When determining hemolysis, use only the blood agar plate; do not judge hemolysis from MacConkey, MSA, or other selective media (or chocolate agar).
• Hemolysis types on blood agar:
  • Alpha (α) hemolysis: green, incomplete hemolysis around the colony. It’s the hemolysis pattern around the colony, not the colony color itself; sometimes described as a brown/green halo. Alpha prime is a rare variant seen with certain streptococci.
  • Beta (β) hemolysis: complete clearing around the colony.
  • Gamma (γ) hemolysis: no hemolysis (nonhemolytic).
• Observation tips:
  • Put plates up to a light source to reveal tiny beta-hemolysis halos around colonies; some halos are very small.
  • Some plates show obvious, extensive beta-hemolysis; others show only a faint halo.
• Colony morphology description components (color, texture, size, hemolysis) help when multiple organisms grow on one plate; consistent description aids others identifying the same plate later (e.g., “gamma-hemolytic white colony”).
• Alpha prime: not common; associated with certain Streptococcus species.
• In clinical micro labs, describe colony morphology for all organisms encountered; this supports downstream identification.
• A note on virulence context: hemolysis patterns are an important phenotypic clue in microbial identification and can relate to toxin production and pathogenic potential.

Colony Morphology: Describing What You See

• Key descriptors to report for each colony:
  • Color: e.g., white, gray, yellow (note that Staphylococcus aureus can be opaque white to golden-yellow).
  • Transparency: opaque, translucent, or transparent.
  • Size: small, medium, large; relative to standard references.
  • Texture: smooth, rough/dry, mucoid, crusty.
  • Hemolysis: α, β, γ, or α′ as observed on blood agar.
• For Staphylococcus aureus, colonies are typically opaque, smooth, and may range from white to yellow; often β-hemolytic.
• For coagulase-negative Staphylococci (CoNS), colonies are typically opaque, white to gray, smooth, and gamma-hemolytic, though there can be exceptions.

Laboratory Sterilization, Autoclaving, and Related Practices

• Sterilization methods and equipment:
  • Incinerators (still used for sterilizing loops in many labs); do not rely on Bunsen burners for sterilization.
  • Autoclaving is a standard sterilization method in microbiology labs; steam under pressure to kill endospores and organisms.
  • Boiling (e.g., for thioglycolate broth) reduces oxygen in tubes but is not ideal for sterilizing and is not reliable for killing endospores; typically 3 × 30 minutes at 100°C is used theoretically to kill endospores if needed.
  • Dry heat ovens are another sterilization method in some labs, but autoclaves are more common.
• Autoclave parameters (typical standard):
  • Parameters: $15 ext{ psi}, ext{ }121^ ext{°C}, ext{ }15 ext{ min}$
  • These are the standard conditions for sterilizing glassware, media, and reusable items in many clinical microbiology settings.
  • Quality control: autoclave efficacy must be validated; improper sterilization leads to contamination and unreliable results.
• Use and management of disposable vs reusable items:
  • Wooden sticks may be used in some labs (instead of metal loops); wooden sticks must be sterilized (autoclaved) before use.
  • Always sterilize equipment before touching auger plates; prevent cross-contamination.
• Spore considerations:
  • Spores are resistant forms of organisms; spores can contaminate equipment if not properly sterilized.
  • Spore formers are considered a major containment concern in microbiology labs.
• Other sterilization and safety options:
  • Dry heat ovens (alternative to autoclaves) and radiation (UV in biosafety hoods; gamma radiation) are used in different contexts.
  • Filtration (HEPA filters) helps prevent contamination spread in hoods and workspaces.
• Practical safety culture in the lab:
  • Work under biological safety guidelines; follow aseptic technique to prevent contamination.
  • Handwashing and appropriate PPE (as needed) are critical; gloves are part of PPE but their use should be paired with proper hand hygiene to avoid false sense of security.
  • In a hood, maintaining containment is essential when handling potentially infectious material or biosafety level 2/3 organisms.

Biosafety Levels, Safety Practices, and PPE

• Biosafety levels (BSL) are categorized by pathogenicity and required containment:
  • BSL-1: Low risk; open bench top work, basic PPE.
  • BSL-2: Moderate risk; typical clinical microbiology lab; work under hood for certain organisms; standard precautions for handling patient specimens; gloves and lab coats as needed.
  • BSL-3: Higher risk; organisms can be transmitted via inhalation; separate rooms with negative air pressure; use of respirators (e.g., N95) and work under a biosafety cabinet; restricted access.
  • BSL-4: Extremely dangerous organisms; often viruses like Ebola; separate building, dedicated air supply, full-body suits with air supply; decontamination procedures.
• Our student clinical microbiology lab scope:
  • Typically a Biosafety Level 2 (BSL-2) facility.
  • Occasional exposure to Biosafety Level 1 organisms; limited exposure to Level 3 organisms; never handling Level 3 pathogenic fungi or open Mycobacterium cultures in this setting.
• Immunocompetence and risk:
  • Immunocompromised individuals (chemotherapy, prolonged corticosteroid use, prolonged antibiotics, autoimmune disease) are more susceptible to infection by organisms that are ordinarily nonpathogenic.
• Aseptic technique and standard precautions:
  • Handwashing, PPE as needed, maintaining cleanliness, preventing contamination of objects, sterile transfer techniques.
  • PPE includes gloves, lab coats, eye protection as appropriate; gloves provide barrier but do not replace hand hygiene.
• Hood and containment specifics:
  • Work with fungal cultures and mycobacterial cultures under biosafety hoods with appropriate shielding and, in higher-containment areas, negative pressure and specialized respiratory protection.
  • Hoods and rooms may include UV or other sterilization features in some settings; filters (HEPA) help prevent aerosol spread.
• Additional safety concepts:
  • Proper air handling and negative pressure spaces reduce risk of environmental contamination and occupational exposure.
  • Negative air pressure in BSL-3 spaces ensures air does not escape to other parts of the lab.

Staphylococcus aureus: Traits, Diseases, and Clinical Relevance

• Habitat and carriage:
  • Normal flora found on skin and in the anterior nares; 20–80% carriage in the general population is common (nasal carriers can shed organisms and risk infection; nasal swabs can identify carriers prior to procedures).
• Gross and microscopic appearance:
  • Gram-positive cocci in clusters; catalase-positive; coagulase-positive in the classic pathogenic form; colonies are typically opaque, smooth, and can be white to yellow; beta-hemolysis on blood agar is common.
• Coagulase status:
  • One coagulase-positive species: Staphylococcus aureus.
  • Coagulase-negative staphylococci (CoNS) are a broader group including S. epidermidis, S. saprophyticus, and S. lugdunensis.
• Hemolysis patterns:
  • S. aureus is typically beta-hemolytic, though exceptions exist where it appears gamma-hemolytic.
• Pathogenic potential and diseases:
  • Localized infections: sinusitis, impetigo, folliculitis, carbuncles, abscesses.
  • Invasive infections: pneumonia, endocarditis, osteomyelitis, sepsis, disseminated infections.
  • Toxic conditions: toxic shock syndrome (TSS) and staphylococcal food poisoning due to exotoxins.
  • Toxin-related diseases include: enterotoxin-mediated food poisoning, exfoliative toxins causing scalded skin syndrome, and TSST-1 causing toxic shock syndrome (classically associated with tampon use but not limited to that).
• Endotoxins vs exotoxins:
  • Exotoxins: produced by live bacteria (Gram-positive or Gram-negative); often localized to specific cell types (e.g., neurotoxins) and can inhibit protein synthesis.
  • Endotoxins: released upon bacterial cell lysis; associated with Gram-negative bacteria (lipid A portion of LPS); lysis of Gram-negative cells can increase endotoxin release and inflammation.
• Virulence and antibiotic resistance:
  • Virulence varies with toxin production and virulence factors; higher virulence can lead to more severe disease.
  • MRSA/ORSA terminology:
  • MRSA = methicillin-resistant Staphylococcus aureus (a beta-lactam resistance phenotype).
  • ORSA = oxacillin-resistant Staphylococcus aureus (alternate naming; some hospitals prefer ORSA).
  • MRSA/ORSA resistance means resistance to many beta-lactam antibiotics; treatment requires alternative agents.
• Transmission and infection control:
  • Can be transmitted person-to-person or via environment; colonization in the nose increases transmission risk.
  • Surgical patients require precautionary measures due to potential colonization and subsequent infection.
• Clinical testing and identification (conceptual flow):
  • Primary screening: Gram-positive cocci in clusters; catalase test to separate Staphylococcus from Streptococcus.
  • If catalase-positive: proceed with Staphylococcus identification; if catalase-negative: move to Streptococcus/Enterococcus workflow.
  • Coagulase testing cascades (slide coagulase, tube coagulase) and latex agglutination (Protein A detection) are used to identify S. aureus.
  • Novobiocin disc testing (for CoNS from urine cultures) helps differentiate S. saprophyticus (novobiocin resistant) from S. epidermidis.
  • Ornithine decarboxylase (ODC) testing is used to differentiate Staphylococcus lugdunensis from other CoNS in some workflows.
  • McFarland standards are used to standardize inoculum density for disc diffusion and other antimicrobial susceptibility testing.
• Practical notes for identification and interpretation:
  • Slide coagulase positives indicate S. aureus; negative results require tube coagulase confirmation (extracellular coagulase) and often overnight reading to avoid misclassification.
  • Latex agglutination for Protein A (a surface protein of S. aureus) can rapidly confirm S. aureus without overnight incubation.
  • False positives in catalase tests can occur due to using contaminated loops or agar; ensure clean technique and avoid blood agar contamination in catalase tests.
• Clinical significance and safety:
  • S. aureus remains a high-priority pathogen in clinical microbiology due to its toxin-mediated diseases and antibiotic resistance patterns.
  • Attributes such as nasal carriage rates, toxin production, and antibiotic resistance influence infection control strategies in healthcare settings.

Coagulase-Negative Staphylococci (CoNS): Key Members and Clinical Relevance

• Major members emphasized in this course:
  • Staphylococcus epidermidis
  • Staphylococcus saprophyticus
  • Staphylococcus lugdunensis (often spelled lugdunensis; previously referred to with various names in the literature)
• General characteristics:
  • Coagulase-negative: do not produce coagulase (unlike S. aureus).
  • Gram-positive cocci arranged in clusters; catalase-positive (like other staphylococci).
  • Colony morphology on standard media: opaque, white to gray, smooth; typically gamma-hemolytic.
  • Commonly part of normal skin and mucosal flora; opportunistic pathogens.
• Clinical significance:
  • Infections are often associated with indwelling devices (catheters, prosthetic valves, prosthetic joints) and implanted materials.
  • Can cause bacteremia and endocarditis, particularly in patients with devices or immunocompromised states.
  • Staphylococcus saprophyticus is a notable cause of urinary tract infections (UTIs), especially in sexually active young women.
• Species-specific notes and differentiation:
  • Staph epidermidis: common on skin; associated with device-related infections; typically novobiocin susceptible.
  • Staph saprophyticus: UTIs; novobiocin resistant; used in differentiation from S. epidermidis.
  • Staph lugdunensis: can cause endocarditis; behaves more like S. aureus in some tests; may have virulence comparable to S. aureus in certain contexts.
• Identification tests and rules of thumb:
  • For CoNS from urine cultures, perform novobiocin disc test to distinguish S. saprophyticus (usually novobiocin resistant) from S. epidermidis (usually novobiocin susceptible).
  • Ornithine decarboxylase (ODC) testing is described as a test relevant to distinguishing S. lugdunensis in some teaching workflows.
• Practical clinical context:
  • While CoNS are common skin flora, they are clinically significant in the setting of medical devices, implanted hardware, and nosocomial infections.

Micrococcus and Rothia: Distinctive Features and Clinical Considerations

• Micrococcus species:
  • Gram-positive cocci; often arranged in tetrads (groups of four).
  • Colony morphology: bright yellow, opaque, and smooth; distinct tetrahedral arrangement on Gram stain.
  • Catalase-positive and oxidase-positive; typically nonpathogenic or opportunistic; common skin/mucosal flora; can be confused with Staphylococcus due to Gram-positive cocci but morphological and biochemical differences help differentiate.
  • Common diagnostic clues in practice:
  • Bright yellow colonies and tetrad arrangement.
  • Oxidase-positive reaction helps distinguish from many staphylococci.
  • Antibiotic susceptibility: often susceptible to bacitracin; often resistant to furazolidone (as noted in teaching materials).
• Rothia mucilaginosa (Stomatococcus mucilaginosus):
  • Gram-positive cocci; can appear in clusters or irregular aggregation; colonies are often mucilaginous and sticky (sticky “tenacious” colonies).
  • Historically known as Stomatococcus mucilaginosus; renamed as Rothia mucilaginosa in many modern manuals.
  • Phenotype:
  • Colony morphology: mucoid/sticky; may appear with a translucent to milky appearance.
  • Biochemical tests may show unique reactions; in practice, may be involved in endocarditis or bacteremia in susceptible hosts.
  • Clinical relevance:
  • Opportunistic pathogen; associated with endocarditis in susceptible patients and other opportunistic infections.

Media, Carriers, and Differential Testing Concepts

• Mannitol Salt Agar (MSA): a key selective-differential medium for nasal carriage screening
  • Contains high salt concentration (7.5% NaCl), which selects for Staphylococcus spp. and inhibits many other flora.
  • Contains mannitol and a pH indicator; if the organism ferments mannitol, acid is produced and the agar turns yellow; if not, it remains pink/red.
  • Interpretation in nasal carriage screening:
  • Yellow colonies indicate Staphylococcus aureus, suggesting a carrier state in the nares.
  • Red/without acid production indicates non-S. aureus staphylococci or other flora.
  • Note: MSA is selective for Staphylococcus spp. and differential for mannitol fermentation; it does not definitively identify MRSA.
• Other media in the course context:
  • CNA (Colistin-Nalidixic Acid) and PEA (Phenylethyl Alcohol) are selective media for Gram-positive organisms.
  • MacConkey is used for Gram-negative selection but is not relevant for identifying Gram-positive cocci (like Staphylococcus, Micrococcus, Enterococcus) on its own.
  • Differential media and pH indicators are used to detect sugar or amino acid utilization that changes the color of the medium.
• Basic biochemistry principles emphasized in the course:
  • Sugar utilization yields acid products, lowering pH; differential media often turn yellow with acid production.
  • Amino acid utilization or proteolysis can yield alkaline products, turning media more basic.
  • These biochemical outcomes drive interpretation of API strips and similar panels.
• Enterococcus note (brief):
  • Enterococcus species may appear blue/blue-green on certain plates or have distinctive appearances; they are Gram-positive cocci often in short chains and can be clinically significant (e.g., urinary tract infections, endocarditis).,
  • PYR testing and other biochemical approaches are used in identification; details depend on the lab protocol.

Identification Procedures, Flowcharts, and Test Concepts

• Core initial step for Gram-positive cocci in a clinical specimen:
  • Perform catalase test first to differentiate Staphylococcus (catalase-positive) from Streptococcus/Enterococcus (catalase-negative).
  • If catalase-positive, proceed with Staphylococcus identification workflows; if catalase-negative, pursue Streptococcus/Enterococcus workflows.
• Staphylococcus identification cascade (conceptual):
  • Slide coagulase test (bound coagulase) to rapidly screen for coagulase-positive staph.
  • If slide coagulase positive, call it Staphylococcus aureus; if slide coagulase negative, proceed to tube (free) coagulase testing for confirmation.
  • Tube coagulase test detects extracellular coagulase by clot formation in plasma; incubation around 4 hours; if negative, incubate overnight to check again.
  • If tube coagulase remains negative after overnight, identify as CoNS (coagulase-negative Staphylococcus).
• Latex agglutination for Protein A (a marker of S. aureus):
  • A latex beads assay coated with anti-Protein A detects S. aureus rapidly (often within minutes); positive indicates S. aureus without needing tube coagulase confirmation.
  • If negative, results may rely on CoNS identification and additional testing.
• Novobiocin disk test (CoNS differentiation, especially from urine isolates):
  • S. saprophyticus is typically resistant to novobiocin; S. epidermidis is usually susceptible (depending on strain and lab protocols).
  • Practical use: from urine isolates with CoNS phenotype, novobiocin testing helps determine if the organism is S. saprophyticus (a common UTI pathogen) vs other CoNS.
• Ornithine decarboxylase (ODC) testing:
  • Used in some teaching workflows to differentiate Staphylococcus lugdunensis from other CoNS; specific to certain clinical labs or educational materials.
• McFarland standards and disc diffusion testing:
  • Standardize inoculum density to a defined turbidity using McFarland standards before performing disc diffusion antibiotic susceptibility tests.
  • Measure zones of inhibition after incubation to determine susceptibility or resistance; interpret according to CLSI guidelines.
• Chromogenic and API-based methods (newer technology):
  • Chromogenic media (Chrome agar, Chrome-Ident products) provide rapid presumptive identification by color changes for specific organisms (e.g., MRSA-specific chromogenic media turning colonies pink vs. blue).
  • API strips and API panels (biochemical panels with multiple wells) yield a code based on positive/negative reactions; this code corresponds to an organism ID in a database.
  • Rapid panels and MALDI-TOF mass spectrometry have become common; MALDI-TOF provides IDs within a few hours and is increasingly used in clinical labs.
• Practical takeaway about flowcharts:
  • Flowcharts help guide manual identification with old-school tests; modern labs often rely on automated systems but understanding the principles remains essential for interpreting results and troubleshooting.

Practical Identification Pitfalls and Tips

• Key distinguishing features to avoid misidentification:
  • Micrococcus can resemble Staphylococcus in Gram stain but has distinctive tetrads and oxidase-positive results; typical bright yellow colonies help differentiate.
  • Rothia mucilaginosa (Stomatococcus mucilaginosus) can appear sticky and mucoid; may be mistaken for Staphylococcus in early steps; further testing helps differentiate.
• Important note on colony color and interpretation:
  • Staph aureus tends to have opaque, smooth colonies that can be white to yellow; many CoNS are white to gray and gamma-hemolytic.
  • Micrococcus shows bright yellow colonies with tetrads; oxidase positive separates it from most Staphylococcus species.
• Antibiotic resistance context:
  • MRSA/ORSA represents Staph aureus strains resistant to methicillin/oxacillin and often resistant to many beta-lactam antibiotics; management requires alternative therapies.
  • Knowledge of local antibiograms and CLSI breakpoints is essential for proper interpretation of susceptibility results.
• Safety reminder in clinical context:
  • Proper use of biosafety practices protects both the patient and the laboratory staff; cross-contamination can alter results and create safety issues.

Differential Media: Enriched, Selective, and Differential Media, plus Relevance

• Enriched media (e.g., blood agar, chocolate agar):
  • Support growth of fastidious organisms; used for general recovery of pathogens from clinical specimens.
• Selective media (e.g., CNA, PEA, MacConkey is used more for Gram-negative selection):
  • Inhibit certain organisms while allowing others to grow; CNA and PEA help select for Gram-positive cocci.
• Differential media (e.g., MSA, various sugar-containing media):
  • Include indicators that reveal metabolic traits (e.g., mannitol fermentation on MSA turning the medium yellow).
• Interpreting differential results:
  • A color change indicates a metabolic activity (acid production from sugar use or alkaline products from amino acid metabolism), guiding presumptive identifications.

Quick Real-World Connections, Ethical/Practical Implications, and Exam-Focused Points

• Relevance to patient care:
  • Correct interpretation of hemolysis, colony morphology, and initial biochemical tests guides timely identification of pathogens and appropriate therapy.
  • Understanding carriers (e.g., nasal carriage of S. aureus) informs infection control measures before surgery.
• Lab safety and ethics:
  • Proper sterilization, aseptic technique, and PPE usage protect both patients and staff; improper practices can lead to contamination and spread of infections.
• Foundational principles:
  • Phenotypic testing (hemolysis, colony morphology, catalase, coagulase, novobiocin, ornithine decarboxylase) underpins modern automated methods (API panels, MALDI-TOF, chromogenic media).
  • Concept of differential media rests on basic biochemical pathways: sugar metabolism (acid production) and amino acid metabolism (alkaline production).
• Practical lab study strategies:
  • Learn to describe colony morphology consistently (color, opacity, texture, size) and correlate with hemolysis patterns.
  • Practice a stepwise flow for Gram-positive cocci identification: Gram stain → catalase → coagulase (slide vs tube) → confirmatory tests (latex agglutination or tube coagulase) → differentiate CoNS (novobiocin for S. saprophyticus) → specialized tests (ODC for lugdunensis) where needed.
• Ethical considerations in clinical microbiology education:
  • Accurate naming and interpretation of organisms during internships to avoid miscommunication and ensure patient safety; terminology matters (e.g., lugdunensis vs other CoNS, MRSA vs ORSA in different institutions).

Quick Reference: Key Facts by Organism and Testing Context

• Staphylococcus aureus
  • Coagulase-positive, beta-hemolysis, opaque, smooth colonies; nasal carrier common; aggressive toxin-mediated disease potential; MRSA/ORSA resistance to many beta-lactams.
  • Tests: catalase positive; slide coagulase positive → S. aureus; latex agglutination (Protein A) positive; novobiocin testing not used to identify S. aureus; exotoxin-mediated diseases possible.
• Coagulase-Negative Staphylococci (CoNS)
  • S. epidermidis, S. saprophyticus, S. lugdunensis emphasized in class.
  • Generally gamma-hemolytic; catalase-positive; novobiocin testing aids distinction for UTIs (S. saprophyticus is typically novobiocin resistant).
  • Clinical relevance: indwelling devices; bacteremia; endocarditis; UTIs (esp. with urinary devices).
• Micrococcus spp.
  • Gram-positive cocci in tetrads; bright yellow colonies; oxidase-positive; common skin flora; usually nonpathogenic but can be mistaken for Staphylococcus spp. in appearance.
• Rothia mucilaginosa (Stomatococcus mucilaginosus)
  • Sticky/mucoid colonies; potential to cause endocarditis and bacteremia in susceptible hosts; clinical relevance as an opportunistic pathogen.
• Media and testing concepts
  • MSA: selective/differential for S. aureus due to 7.5% NaCl and mannitol-fermenting capability; yellow indicates acid production and mannitol fermentation.
  • CNA/PEA: Gram-positive selectors.
  • Hemolysis: key differentiator for many organisms; observe on blood agar with proper lighting.
  • Novobiocin: differentiate S. saprophyticus ( resistant) from S. epidermidis (susceptible).
  • Ornithine decarboxylase: differentiates certain CoNS species (e.g., lugdunensis) in some teaching contexts.
  • API strips and chromogenic media: educational tools; MALDI-TOF as modern IDs; CLSI standards for interpretation and QC.